• Study of MK-3120 for patients with high-risk non-muscle invasive bladder cancer who have not received or have received BCG treatment

    Recruiting

    1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Austria Belgium France Greece Italy The Netherlands +2
  • Study of How Enzalutamide and Apalutamide Affect Dexamethasone Processing in the Body in Patients with Prostate Cancer

    Recruiting

    3 1 1 1
    Sweden
  • A study testing capsaicin patches compared to placebo for patients with painful diabetic nerve damage to assess effects on nerve symptoms and nerve fibers

    Recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    Germany
  • A Study Testing the Safety of IRL757 in Adults with Parkinson’s Disease Who Have Apathy

    Recruiting

    1 1
    Investigated Diseases:
    Bulgaria Germany Poland Spain
  • Study of Heart and Blood Vessel Side Effects in Cancer Patients Receiving Immune Checkpoint Inhibitor Drug Combination Treatment

    Recruiting

    3 1 1 1
    Hungary
  • Study of flumazenil for preventing emergence delirium in children after ear, nose and throat surgery

    Recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    Germany
  • A Study Comparing Melatonin versus Placebo for Mood Stabilization in Patients with Bipolar Disorder

    Recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    Denmark
  • Sodium-glucose cotransporter-2 inhibitor drug combination for patients with diabetes and heart attack to slow coronary artery disease progression

    Recruiting

    3 1 1 1
    Italy
  • Testing Caffeine Citrate for Reducing Breathing Support Needs in Premature Newborns with Primary Apnea

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Czechia
  • A Study of Visugromab Compared to Placebo in Patients with Cancer-Related Cachexia to Test How Well It Works and How Safe It Is

    Recruiting

    4 1
    Investigated Drugs:
    Bulgaria Czechia France Germany Ireland Italy +5

powered by